Testing SUM-191 eye drops for bacterial pink eye
Part of Eyes & vision, Infections clinical trials.
This trial tests a new eye medication called SUM-191 for treating bacterial conjunctivitis (a bacterial infection that causes pink eye). The study has three parts: first testing safety in healthy people, then in people with the infection itself.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old and in generally good health (for Parts 1–2) or have bacterial conjunctivitis diagnosed by a doctor (for Part 3)
- You are willing to stop wearing contact lenses for the entire trial
- You have not taken antibiotics or anti-inflammatory eye drops in the past 72 hours
- You do not have corneal ulcers, herpes in your eyes, severe dry eye, recent eye surgery, or uncontrolled glaucoma
- You agree to use contraception if you can become pregnant, and not donate blood, sperm, or eggs during the trial
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an antibiotic eye drop called fusidic acid for bacterial conjunctivitis (pink eye). It may help clear the infection if you have had symptoms for less than 48 hours and have not used other eye treatments recently.
This trial tests whether a new eye drop called BT01001 is safe for healthy adults. You may join if you have good overall and eye health, and do not use contact lenses or have chronic eye problems.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
This study tests a new eye drop called PRO-190 to see if it's safe and comfortable for the eyes, comparing it to a common artificial tear (Systane Ultra). It is for healthy people and may help if you have dry or irritated eyes.
This study tests an investigational eye drop called OT202 to see if it helps people with moderate to severe dry eye. If you join, you'll receive either the study drug or a placebo (no active ingredient) and have your symptoms and eye health monitored for several months.
This trial tests a new eye drop called PAN-90806 in healthy people to see if it is safe and how the body handles it. Participants will receive the eye drops and be closely monitored.
Hear when a new Bacterial Conjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.